Cambridge biotech Spero bags $51M as GV joins latest round Posted on March 8, 2017 at 12:20 am.Written by Spero Therapeutics Post navigation Dunsire Joins Xtuit to Fight Microenvironment; Spero Gets $51.7M for AntibioticsGoogle’s venture arm leads Spero’s $51.7M round for R&D work on a pipeline of new antibiotics
